Robuta

https://medicaex.com/prnewswire/lunit-secures-150-million-in-capital-increase/ Lunit Secures $150 Million in Capital Increase - MedicaEx.com Nov 16, 2023 - Fund fully paid-in as of November 9, achieving over 100% shareholder participation capital increaselunitmillion https://biopharmaapac.com/news/76/7286/lunit-submits-fda-510k-for-ai-driven-five-year-breast-cancer-risk-prediction-model.html Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model breast cancer riskfor ailunitfdadriven https://aithority.com/machine-learning/lunit-to-supply-ai-platform-to-australias-breastscreen-nsw-machine-reading-project/ Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project Nov 16, 2022 - Lunit, medical AI provider serving over 1,000 sites around the world, announced that it has signed a contract to supply its AI solution ai platformbreastscreen nswlunitsupplyaustralia https://www.toscanamedianews.it/tag/festa-de-lunit Festa De Lunit Qui News toscanamedia festadelunitquinews https://www.laboratorynetwork.com/doc/lunit-labcorp-to-advance-ai-powered-digital-pathology-research-0001 11.25.25 -- Lunit & Labcorp To Advance AI-Powered Digital Pathology Research 11/25/25 Laboratory Network Newsletter ai powereddigital pathologylunitlabcorpadvance https://www.medicaldevice-network.com/news/lunit-fda-breast/ Lunit seeks FDA clearance for breast cancer risk prediction model Dec 9, 2025 - Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US FDA for its breast cancer risk prediction model. breast cancer riskfda clearancelunitseeksprediction https://healthairegister.com/pathology/products/lunit-scope-pd-l1 Lunit SCOPE PD-L1 - Lunit Lunit SCOPE PD-L1 by Lunit - Advanced healthcare AI solution. lunitscopepd https://theimagingwire.com/2025/09/03/lunit-is-ramping-up-its-position-in-breast-cancer-risk/ Lunit Acquires Prognosia Breast Cancer Risk AI - The Imaging Wire Sep 4, 2025 - Lunit is ramping up its position in breast cancer risk prediction by acquiring Prognosia, the developer of a risk prediction algorithm. breast cancer risklunitaiimagingwire https://www.biospace.com/lunit-expands-reach-of-its-ai-powered-chest-screening-solution-to-global-military-health-institutions Lunit Expands Reach of its AI-Powered Chest Screening Solution to Global Military Health... Nov 10, 2023 - Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced the successful supply of its AI-powered chest... ai poweredmilitary healthlunitexpandsreach https://aimonstr.com/tool/lunit-io-en Lunit - AIMonstr Lunit AI leverages advanced artificial intelligence to enhance cancer detection and treatment, backed by strong research and global adoption across... lunitaimonstr https://mercomcapital.com/tag/lunit/ Lunit Archives - Mercom Capital Group mercom capital grouplunitarchives https://www.marketscreener.com/news/lunit-presents-six-ai-studies-at-aacr-2026-highlighting-advances-in-precision-oncology-and-real-worl-ce7e50d3da8bf122 Lunit Presents Six AI Studies At AACR 2026 Highlighting Advances in Precision Oncology and... Apr 17, 2026 - Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor... ai studiesprecision oncologylunitpresentssix https://www.ucwe.com/tag/lunit/ lunit - The UCW Newswire : Global Financial, Business and Tech News business and techlunitucwnewswireglobal